Maria A Horga, MD

Locations

Annenberg Building Floor 17 Room 06, 1468 Madison Ave, New York, NY, 10029

Annenberg Building Floor 23 Room 275, 1468 Madison Ave, New York, NY, 10029

Publications

Selected Publications

• Derivation of phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates. Xiaodong Wang, Matthew Hruska, Phyllis Chan, Alaa Ahmad, Jeremy Freeman, Maria Arantxa Horga, Jan Hillson, Vikram Kansra, Juan Carlos Lopez-Talavera. Journal of Clinical Pharmacology
• Derivation of phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 2: Exposure-response analyses for efficacy and safety variables. Matthew Hruska, Xiaodong Wang, Phyllis Chan, Alaa Ahmad, Jeremy Freeman, Maria Arantxa Horga, Jan Hillson, Vikram Kansra, Juan Carlos Lopez-Talavera. Journal of Clinical Pharmacology
• A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. Andrew J. Muir, Sanjeev Arora, Gregory Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein, Jan Hillson, Maria Arantxa Horga, Ira M. Jacobson, Lennox Jeffers, Kris V. Kowdley, Eric Lawitz, Stefan Lueth, Maribel Rodriguez-Torres, Vinod Rustgi, Lynn Shemanski, Mitchell L. Shiffman, Subasree Srinivasan, Hugo E. Vargas, John M. Vierling, Dong Xu, Juan C. Lopez-Talavera, Stefan Zeuzem. Journal of Hepatology